EUVIMEDEUVIMED entdecken
Open Access

Pharmacological inhibition of histamine N -methyltransferase extends wakefulness and suppresses cataplexy in a mouse model of narcolepsy

Fumito Naganuma, Birkan Girgin, Anne Bernadette S Agu, Kyosuke Hirano, Tadaho Nakamura, Kazuhiko Yanai, Ramalingam Vetrivelan, Takatoshi Mochizuki iD, Masashi Yanagisawa iD, Takeo Yoshikawa iD

SLEEP · 2025

DOI: 10.1093/sleep/zsae244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SLEEP, 2025. Verfasst von Fumito Naganuma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropharmacology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan. Hauptthemen laut MEDLINE: Narcolepsy, Wakefulness, Histamine N-Methyltransferase, Cataplexy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Japan Agency for Medical Research and Development, Grant-in-Aid for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histamine, a neurotransmitter, plays a predominant role in maintaining wakefulness. Furthermore, our previous studies showed that histamine N-methyltransferase (HNMT), a histamine-metabolizing enzyme, is important for regulating brain histamine concentration. However, the effects of pharmacological HNMT inhibition on mouse behavior, including the sleep–wake cycle and cataplexy, in a mouse model of narcolepsy have not yet been investigated. In the present study, we investigated the effects of metoprine, an HNMT inhibitor with high blood-brain barrier permeability, in wild-type (WT) and orexin-deficient (OxKO) narcoleptic mice. Metoprine increased brain histamine concentration in a time- and dose-dependent manner without affecting peripheral histamine concentrations. Behavioral tests showed that metoprine increased locomotor activity in both novel and familiar environments, but did not alter anxiety-like behavior. Sleep analysis showed that metoprine increased wakefulness and decreased non-rapid eye movement (NREM) sleep through the activation of the histamine H1 receptor (H1R) in WT mice. In contrast, the reduction of rapid eye movement (REM) sleep by metoprine occurred independent of H1R. In OxKO mice, metoprine was found to prolong wakefulness and robustly suppress cataplexy. In addition, metoprine has a greater therapeutic effect on cataplexy than pitolisant, which induces histamine release in the brain and has been approved for patients with narcolepsy. These data demonstrate that HNMT inhibition has a strong effect on wakefulness, demonstrating therapeutic potential against cataplexy in narcolepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NarcolepsyWakefulnessHistamine N-MethyltransferaseCataplexyAnimalsMiceDisease Models, AnimalHistamineMice, KnockoutMaleBrainMice, Inbred C57BLOrexins

Stichwörter der Autor:innen

histaminehistamine N-methyl transferasemetoprinenarcolepsywakefulness

Substanzen

Histamine N-MethyltransferaseHistamineOrexins

Autor:innen und Institutionen

  • Department of Neuropharmacology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.
  • Department of Pharmacology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan.
  • Division of Bioregulatory Pharmacology, Department of Pharmacology, Iwate Medical University, Iwate, Japan.
  • Cyclotron and Radioisotope Center, Tohoku University, Miyagi, Japan.
  • Department of Neurology, Beth Israel Deaconess Medical Center and Division of Sleep Medicine, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Takatoshi Mochizuki, Masashi Yanagisawa, Takeo Yoshikawa

Förderung

  • NINDS NIH HHS
  • Japan Agency for Medical Research and Development
  • Grant-in-Aid for Scientific Research
  • World Premier International Research Center Initiative
  • Japan Society for the Promotion of Science
  • Akiyama Life Science Foundation
  • Takeda Science Foundation
  • National Institutes of Health

Zitieren

APA

Naganuma, F., Girgin, B., Agu, A. B. S., Hirano, K., Nakamura, T., Yanai, K., Vetrivelan, R., Mochizuki, T., Yanagisawa, M., & Yoshikawa, T. (2025). Pharmacological inhibition of histamine N -methyltransferase extends wakefulness and suppresses cataplexy in a mouse model of narcolepsy. SLEEP. https://doi.org/10.1093/sleep/zsae244

Vancouver

Naganuma F, Girgin B, Agu ABS, Hirano K, Nakamura T, Yanai K, et al. Pharmacological inhibition of histamine N -methyltransferase extends wakefulness and suppresses cataplexy in a mouse model of narcolepsy. SLEEP. 2025. doi:10.1093/sleep/zsae244

BibTeX
@article{Naganuma2025,
  author = {Naganuma, Fumito and Girgin, Birkan and Agu, Anne Bernadette S and Hirano, Kyosuke and Nakamura, Tadaho and Yanai, Kazuhiko and Vetrivelan, Ramalingam and Mochizuki, Takatoshi and Yanagisawa, Masashi and Yoshikawa, Takeo},
  title = {Pharmacological inhibition of histamine N -methyltransferase extends wakefulness and suppresses cataplexy in a mouse model of narcolepsy},
  journal = {SLEEP},
  year = {2025},
  doi = {10.1093/sleep/zsae244}
}
Kostenlos starten →